Clinical Trial Update: Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin Alfa [Phase 2]

View source ↗

Summary

Phase 2 study to develop a screening tool for functional capacity in anemic patients with nonmyeloid malignancies undergoing chemotherapy and treated with darbe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Nonmyeloid Malignancies

Drugs mentioned

• Darbepoetin alfa (Aranesp) (darbepoetin alfa)

Snippet

Sponsor: Amgen | Conditions: Anemia, Non-Myeloid Malignancies | Phase 2 | Status: COMPLETED